Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data

被引:77
|
作者
Ames, PRJ
Margarita, A
Sokoll, KB
Weston, M
Brancaccio, V
机构
[1] Gen Infirm, Acad Dept Rheumatol, Leeds LS1 3EX, W Yorkshire, England
[2] St Jamess Univ Hosp, Dept Radiol, Leeds LS9 7TF, W Yorkshire, England
[3] Cardarelli Hosp, Angiol Unit, I-80100 Naples, Italy
[4] Cardarelli Hosp, Coagulat Unit, I-80100 Naples, Italy
关键词
D O I
10.1136/ard.2004.023952
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate the atherosclerosis hypothesis in primary antiphospholipid syndrome (PAPS). Methods: The intima media thickness (IMT) of carotid arteries and other cardiovascular risk factors was measured in 20 patients with PAPS (mean (SD) age 35 (12) years) and in 20 controls matched for age and sex (34 (12) years). Results: The frequency of smoking, hypertension, and dyslipidaemia was similar in the two groups, but plasma homocysteine was higher in patients with PAPS (mean (SD) 11.9 (6.2) v 8.2 (3.4) mmol/l, p = 0.037). The IMT was slightly greater in patients with PAPS than in controls at the carotid bifurcation (mean (SD) 0.61 (0.24) v 0.48 (0.09) mm, p = 0.04) and internal carotid artery (0.52 (0.22) v 0.40 (0.08), p = 0.01). These differences were more evident in patients aged >40 years than in those aged <30 years at the carotid bifurcation (0.76 (0.25) v 0.55 (0.06), p = 0.0007) and internal carotid artery (0.63 (0.25) v 0.45 (0.09), p = 0.02); no differences were seen in the younger age group compared with controls. Conclusion: Atherosclerosis is a possibility in patients with PAPS in their fourth decade of life or older.
引用
收藏
页码:315 / 317
页数:3
相关论文
共 50 条
  • [31] PRIMARY ANTIPHOSPHOLIPID SYNDROME
    ASHERSON, RA
    HUGHES, GRV
    AMERICAN JOURNAL OF MEDICINE, 1993, 94 (03): : 345 - 346
  • [32] PRIMARY ANTIPHOSPHOLIPID SYNDROME
    MORALEJA, JG
    SANCHEZ, PS
    SANJUAN, JAG
    ARRIBI, MM
    MEDICINA CLINICA, 1995, 104 (06): : 238 - 238
  • [33] A PRIMARY ANTIPHOSPHOLIPID SYNDROME
    ASHERSON, RA
    JOURNAL OF RHEUMATOLOGY, 1988, 15 (12) : 1742 - 1745
  • [34] PRIMARY ANTIPHOSPHOLIPID SYNDROME
    ALARCONSEGOVIA, D
    SANCHEZGUERRERO, J
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (04) : 482 - 488
  • [35] Risk factors of atherosclerosis and antiphospholipid syndrome
    Seredavkina, N. V.
    Reshetnyak, Tm.
    Alexandrova, E. N.
    Novikov, A. A.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 481 - 481
  • [36] PRIMARY ANTIPHOSPHOLIPID SYNDROME
    ASHERSON, RA
    MCKEE, PH
    FARRANT, JM
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1990, 15 (03) : 234 - 234
  • [37] Atherosclerosis and the antiphospholipid syndrome: A link unravelled?
    Shoenfeld, Y
    Harats, D
    George, J
    LUPUS, 1998, 7 : S140 - S143
  • [38] PRIMARY ANTIPHOSPHOLIPID SYNDROME
    ORDI, J
    BARQUINERO, J
    MEDICINA CLINICA, 1989, 93 (15): : 581 - 587
  • [39] Primary antiphospholipid syndrome
    Cabane, J
    Chazouilleres, O
    Karsenty, P
    Lagier, A
    Poupon, R
    Imbert, JC
    REVUE DE MEDECINE INTERNE, 1997, 18 : S357 - S358
  • [40] Insights into atherosclerosis therapy in antiphospholipid syndrome
    Belizna, Cristina C.
    Richard, Vincent
    Thuillez, Christian
    Levesque, Herve
    Shoenfeld, Yehuda
    AUTOIMMUNITY REVIEWS, 2007, 7 (01) : 46 - 51